Literature DB >> 1085238

Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.

S Gupta, R A Good, F P Siegal.   

Abstract

Peripheral blood lymphocytes from healthy control subjects were studied for spontaneous rosette-formation with mouse erythrocytes. The mean percentage of mouse erythrocyte rosette-forming cells (MRFC) in sixty-three subjects was 7.4X3.5; after neuraminidase treatment olymphocytes the mean percentage of mouse erythrocyte rosette-forming cells(NMRFC) was 17.2X5.6. Thymus cell suspensions made only occasional rosettes with mouse erythrocytes. There was no effect of neuraminidase treatment of thymocytes on mouse erythrocyte rosette-formation. Double labelling experiments with other cell surface markers confirmed this binding of mouse erythrocytes to be a B-cell characteristic. Monocytes and granulocytes do not bind mouse erythrocytes. It appears that there is a distinct receptor for the binding of mouse erythrocytes on the surface of lymphocytes carrying surface immunoglobulins; neuraminidase treatment of lymphocytes permits this binding to occur also on virtually all the non-T cells B cells plus the third population cells).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085238      PMCID: PMC1541346     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Inhibition of human lymphocyte rosetting by anti-T sera.

Authors:  H H Worth; A G Cooper; M C Brown
Journal:  Nat New Biol       Date:  1973-05-23

2.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

3.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

4.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

5.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

6.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

7.  Specificity of human lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

8.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells.

Authors:  Z Bentwich; S D Douglas; E Skutelsky; H G Kunkel
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  38 in total

1.  beta-D-N-acetylglucosaminidase, a new cytochemical marker of human lymphocyte subpopulations.

Authors:  E Orye; Y Benoit; L Roesbeke; M De Wilde; M Van Yper
Journal:  Histochemistry       Date:  1985

2.  Surface marker and other characteristics of Gaucher's cells.

Authors:  G F Burns; J C Cawley; R J Flemans; K E Higgy; C P Worman; C R Barker; B E Roberts; F G Hayhoe
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

3.  Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients.

Authors:  S Gupta; R A Good
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

4.  A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.

Authors:  R J Lukes; C R Taylor; J W Parker; T L Lincoln; P K Pattengale; B H Tindle
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

5.  Studies of the human lymphocyte-mouse erythrocyte bond.

Authors:  P D Zalewski; I J Forbes
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Rosette formation with mouse erythrocytes. IV. T, B and third population cells in human tonsils.

Authors:  S Gupta; R Pahwa; F P Siegal; R A Good
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

7.  Rosette-formation with mouse red blood cells in chronic lymphocytic leukemia and leukemic non-Hodgkin's lymphomas.

Authors:  R Wirthmüller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1980-07-15

8.  Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.

Authors:  E Kuhlein; G Laurent; F Rigal; G Delsol; J Pris; J Ducos
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  Rosette-increasing factor (RIF) generated in vivo following PHA skin test.

Authors:  M Kubota; H Mikawa
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

10.  Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.

Authors:  S S Witkin; S K Shahani; S Gupta; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.